A carregar...
Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studies
The importance of speed to clinic for medicines that may address unmet medical needs puts pressure on product development timelines. Historically, both toxicology and first-in-human clinical materials are generated using the same clonal-derived cells to ensure safety and minimize any development ris...
Na minha lista:
| Publicado no: | MAbs |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7531531/ https://ncbi.nlm.nih.gov/pubmed/32449878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2020.1763727 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|